LAQV REQUIMTE

(Chemical) Bonding is what makes life possible

Paula Gomes

Back

Research group
Molecular Synthesis

Position
Academic Staff

Researcher IDC-6698-2008
Ciência ID551B-A54A-BC60
Paula A. C. Gomes is an Associate Professor, with Habilitation in Chemistry, at the Department of Chemistry and Biochemistry of the Faculty of Sciences of the University of Porto (FCUP), Portugal.

Paula research goals include (i) antimalarial drug rescuing and repurposing, and (ii) antimicrobial peptide-based materials and strategies to fight antibiotic-resistant infections. Paula is also the coordinator of the peptide synthesis core facility in FCUP.

Paula is one of the Chairpersons of the Chemistry in Life Sciences Division of the Portuguese Chemistry Society, the Secretary of the European Peptide Society, and an Associate Member of Division VII – Chemistry and Human Health, of the International Union for Pure and Applied Chemistry.

Representative Publications

ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model
10.1016/j.biomaterials.2017.08.020
"Recycling" classical drugs for malaria
10.1021/cr500123g
Characterization of hLF1-11 immobilization onto chitosan ultrathin films, and its effects on antimicrobial activity
10.1016/j.actbio.2014.02.028
N-cinnamoylation of antimalarial classics: Quinacrine analogues with decreased toxicity and dual-stage activity
10.1002/cmdc.201300459
Selective albumin-binding surfaces modified with a thrombin-inhibiting peptide
10.1016/j.actbio.2013.11.023
N-Cinnamoylated chloroquine analogues as dual-stage antimalarial leads
10.1021/jm301654b
N-cinnamoylated aminoquinolines as promising antileishmanial agents
10.1128/AAC.00557-13
Novel cinnamic acid/4-aminoquinoline conjugates bearing non-proteinogenic amino acids: Towards the development of potential dual action antimalarials
10.1016/j.ejmech.2012.05.022
Peptidomimetic and organometallic derivatives of primaquine active against Leishmania infantum
10.1128/AAC.00873-12
Imidazoquines as antimalarial and antipneumocystis agents
10.1021/jm900738c
Structure-activity relationships for dipeptide prodrugs of acyclovir: Implications for prodrug design
10.1016/j.ejmech.2008.08.009
Antigenicity modulation upon peptide cyclization: Application to the GH loop of foot-and-mouth disease virus strain C1-Barcelona
10.1016/S0264-410X(01)00047-0
Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus
10.1128/JVI.75.7.3164-3174.2001
New Potent Membrane-Targeting Antibacterial Peptides from Viral Capsid Proteins
10.3389/fmicb.2017.00775
Unravelling a Mechanism of Action for a Cecropin A-Melittin Hybrid Antimicrobial Peptide: The Induced Formation of Multilamellar Lipid Stacks
10.1021/acs.langmuir.7b03639
Synergistic and antibiofilm properties of ocellatin peptides against multidrug-resistant Pseudomonas aeruginosa
10.2217/fmb-2017-0175
Wound-Healing Peptides for Treatment of Chronic Diabetic Foot Ulcers and Other Infected Skin Injuries
10.3390/molecules22101743
A novel synthetic peptide inspired on Lys49 phospholipase A(2) from Crotalus oreganus abyssus snake venom active against multidrug-resistant clinical isolates
10.1016/j.ejmech.2018.02.055
Hydrogel depots for local co-delivery of osteoinductive peptides and mesenchymal stem cells
10.1016/j.jconrel.2014.06.030